SLQT Investors Have the Opportunity to Lead the SelectQuote Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of misleading practices related to Medicare insurance plans, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by October 10, 2025 [4]. Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote and its executives violated federal securities laws by making false and misleading statements, including directing Medicare beneficiaries to plans that compensated SelectQuote the most, regardless of quality [6]. - It is claimed that SelectQuote did not provide unbiased comparisons for Medicare Advantage plans and received illegal kickbacks to steer beneficiaries towards certain insurers [6]. - The U.S. Department of Justice filed a complaint stating that from 2016 to at least 2021, SelectQuote received tens of millions of dollars in illegal kickbacks, leading to materially false claims about offering unbiased coverage comparisons [7]. Group 2: Financial Impact - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, amid unusually heavy trading volume [7]. Group 3: Legal Proceedings - Investors who suffered losses exceeding $75,000 in SelectQuote between September 9, 2020, and May 1, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights [1]. - The role of lead plaintiff in the class action is open to any member of the putative class, with the ability to share in any recovery not affected by the decision to serve as lead plaintiff [8].